factors as well as get rid of waste products. [7] Three-dimensional (3D) bioprinting holds great promise as a versatile tool for replicating the spatial complexity of vascularized tissues. [8,9] For example, coaxial extrusion bioprinting can be used to fabricate cell-laden hollow microfibers that function as perfusable lumens. However, 3D networks of interconnected perfusable lumens with structural complexity is as yet difficult to achieve. [10][11][12][13] Both 3D extrusion bioprinting with fugitive inks and digital light processing (DLP)-based bioprinting enable the production of 3D networks of interconnected channels, which can be post-seeded with endothelial cells. [14][15][16] However, both processes involve multiple steps including template removal, repeated cleansing, and post-seeding. [17][18][19] These post-procedures could influence the structural precision, and forfeit inherent advantages of 3D additive manufacturing, such as rapid-prototyping and simplicity. More importantly, most templated materials used in these approaches, such as Pluronic F-127 and carbohydrate glass, are either unsuitable for carrying cells, or highly toxic to cells. [20][21][22] Thus, these approaches do not support in situ seeding of cells, which requires high seeding efficiency and uniformity. [18] To circumvent the challenge of achieving both structural printability and in situ cell seeding, embedded bioprinting is